Search - tctmd.com

Displaying 1 - 20 of 532

Sort: Relevancy | Date

Presentation TCT 2025

Primary Results from the ATHENS-HF Trial: An FIH Study of the Chronically-Adjustable, Biatrial Pressure Sensing Interatrial Shunt (Adona Medical)

Presenter: Gregg W. Stone

October 28, 2025

Presentation TCT 2025

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

Presenter: Gregg W. Stone

October 28, 2025

Presentation TCT 2025

RELIEVE-HF Study Design and Results

Presenter: Gregg W. Stone

October 27, 2025

Presentation TCT 2025

M-TEER in Secondary MR: What the Clinical Evidence Shows

Presenter: Gregg W. Stone

October 27, 2025

Presentation TCT 2025

TCT 531: Early Clinical Experience with a Chronically-Adjustable, Biatrial Pressure Sensing Interatrial Shunt for Heart Failure: Adona Medical

Presenter: Gregg W. Stone

October 27, 2025

Presentation TCT 2025

Position 1: DES

Presenter: Gregg W. Stone

October 26, 2025

Presentation NY Valves 2025

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Presenter: Gregg W. Stone

June 25, 2025

Presentation THT 2025

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Presenter: Gregg Stone

February 13, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation TCT 2024

Vulnerable Plaque: What’s Next?

Presenter: Gregg Stone

October 30, 2024

Presentation TCT 2024

OCCUPI

Presenter: Gregg Stone

October 30, 2024

Presentation TCT 2024

The RECHARGE revascularization trial in women and under-represented minority patients

Presenter: Gregg Stone

October 29, 2024

Presentation TCT 2024

The Most Interesting ‘M-TEER in SMR’ Studies of 2024

Presenter: Gregg Stone

October 29, 2024

Presentation ACC 2024

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Presenter: Gregg W Stone

April 07, 2024

Presentation ACC 2024

Principal Results from the RELIEVE-HF Trial

Presenter: Gregg W. Stone

April 06, 2024

Presentation TCT 2023

Addressing Microvascular Obstruction with SSO2

Presenter: Gregg Stone

October 25, 2023

Presentation TCT 2023

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Presenter: Gregg Stone

October 25, 2023

Presentation ESC 2023

Intravascular Imaging Guidance for PCI: A “Real-Time” Updated Network Meta-analysis

Presenter: Gregg W. Stone

August 28, 2023

Presentation Complex Coronary Cases 2023

PCI vs CABG vs OMT in Patients with LV Dysfunction: PCI is the Treatment of Choice (for most patients)

Presenter: Gregg W. Stone

June 15, 2023

Presentation THT 2023

5-Year COAPT Outcomes With MitraClip in FMR

Presenter: Gregg Stone

March 22, 2023

Advertisement

Primary Results from the ATHENS-HF Trial: An FIH Study of the Chronically-Adjustable, Biatrial Pressure Sensing Interatrial Shunt (Adona Medical)

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

RELIEVE-HF Study Design and Results

M-TEER in Secondary MR: What the Clinical Evidence Shows

TCT 531: Early Clinical Experience with a Chronically-Adjustable, Biatrial Pressure Sensing Interatrial Shunt for Heart Failure: Adona Medical

Position 1: DES

Mitral TEER in Symptomatic FMR: Emerging Data and Futuristic Trends

Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Vulnerable Plaque: What’s Next?

OCCUPI

The RECHARGE revascularization trial in women and under-represented minority patients

The Most Interesting ‘M-TEER in SMR’ Studies of 2024

Principal Results From the Double-blind, Placebo-controlled ULTIMATE-DAPT Trial

Principal Results from the RELIEVE-HF Trial

Addressing Microvascular Obstruction with SSO2

Bivalirudin Is the Most Evidence Based Antithrombin Agent for Primary PCI

Intravascular Imaging Guidance for PCI: A “Real-Time” Updated Network Meta-analysis

PCI vs CABG vs OMT in Patients with LV Dysfunction: PCI is the Treatment of Choice (for most patients)

5-Year COAPT Outcomes With MitraClip in FMR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content